Blog
-
Geneformer-guided multiomics identifies Pbx1 as a network hub of HSC aging
Published : 09/16/2026Authors: Hiroshi Kobayashi et al. Source: Science Advances. They integrated deep learning foundation models with transcriptomic and epigenetic profiling to...
-
Our cationic poloxamers patent is now granted in Australia
Published : 09/09/2026Patent No. AU2020314617, “CATIONIC POLOXAMERS AND THEIR USE IN TRANSDUCTION,” covers our method for synthetically modifying poloxamers to confer additional biological properties...
-
Caspase-3 regulates RNA splicing and mitochondrial dynamics in microglia
Published : 09/02/2026Authors: Medina-Guzmán, R., et al. Source: Cell Death Dis. They showed that basal caspase-3 activity regulates RNA splicing in microglia, and its deficiency in a Parkinson's disease...
-
How Magnetofection unlocks high-efficiency CRISPR Genome Editing
Published : 08/25/2026Paper from: Go I, Lee SH. Front Genome Ed. A controlled, head-to-head benchmark of PolyMag Neo magnetofection against lipofection across Cas9, Cas12, prime editing and RNP delivery.
-
HIV-1-specific CAR-T cell activity enhanced by IL-15 and TGF-β modulation
Published : 08/19/2026Authors: Lamcaj S et al. Source: Journal of Virology. They demonstrated that HCW9218, a bifunctional immunomodulatory protein composed of TGF-βRII...
-
White paper: LentiBlast Premium, cationic poloxamers for lentiviral transduction
Published : 08/11/2026This white paper shows how LentiBlast Premium, a patented cationic poloxamer, enhances lentiviral transduction of CD34+ HSCs at lower viral doses, preserving cell viability.
-
Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery
Published : 08/05/2026Authors: Mathieu Repellin et al. Source: Journal of Controlled Release. They demonstrated that muscle cells are not just passive recipients but vital antigen-producing...
-
Distinct antigen presentation drives potent T cell immunity in mRNA-LNP vaccines
Published : 07/29/2026Authors: Ryunosuke Muro et al. Source: Science Advances. They identified an unconventional antigen presentation pathway driven by migratory type 2...





